David Oxley
Commander · DISC type DDavid Oxley is the CEO of Vaccinogen, spearheading the global strategy for OncoVAX®, a personalized immunotherapy for Stage II colon cancer. An alumnus of Johns Hopkins University with over 25 years in biotechnology and life sciences, his expertise spans capital markets, cross-border licensing, and navigating FDA regulatory pathways for novel therapies.
He holds Series 7 and 63 securities licenses, an uncommon qualification for a biotech CEO that highlights his distinct expertise in corporate finance and investor relations.
Read the full overview →How David shows up
They like to stay in control of the negotiation or defining of the terms. They prefer to move quickly, and expect the same from others. They put a lot of effort into ensuring personal success.
Topics David cares about
Work history
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.